Success Metrics

Clinical Success Rate
92.3%

Based on 12 completed trials

Completion Rate
92%(12/13)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
1(8%)

Phase Distribution

Ph phase_2
10
77%
Ph phase_1
2
15%

Phase Distribution

2

Early Stage

10

Mid Stage

0

Late Stage

Phase Distribution12 total trials
Phase 1Safety & dosage
2(16.7%)
Phase 2Efficacy & side effects
10(83.3%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

92.3%

12 of 13 finished

Non-Completion Rate

7.7%

1 ended early

Currently Active

0

trials recruiting

Total Trials

13

all time

Status Distribution
Completed(12)
Terminated(1)

Detailed Status

Completed12
Terminated1

Development Timeline

Analytics

Development Status

Total Trials
13
Active
0
Success Rate
92.3%
Most Advanced
Phase 2

Trials by Phase

Phase 12 (16.7%)
Phase 210 (83.3%)

Trials by Status

terminated18%
completed1292%

Recent Activity

Clinical Trials (13)

Showing 13 of 13 trials
NCT00359177Phase 1

Observational Study Evaluating The Processing Or Breakdown Of GW679769 In Subjects With Hepatic Impairment

Completed
NCT00650871Phase 2

A Study to Evaluate the Effects of GW679769 on Sleep and Cognitive Function in Subjects With Primary Insomnia

Completed
NCT00274690Phase 2

Post-Operative Nausea And Vomiting Study In Female Patients

Completed
NCT00413023Phase 2

Study Of The Effects Of A New Antidepressant Therapy In Patients With Major Depressive Disorder (MDD)

Completed
NCT00332319Phase 2

Effects Of GW679769 On Bladder Nerve Function And Symptoms Of Overactive Bladder In Spinal Cord Injury Patients

Terminated
NCT00102492Phase 2

Study Of GW679769 In Major Depressive Disorder

Completed
NCT00280436Phase 2

Effects Of GW679769 On Sleep Onset And Maintenance,And Next Day Functioning In The Elderly And Non-elderly With Primary Insomnia

Completed
NCT00264628

GW679769 In Fibromyalgia

Completed
NCT00354809Phase 2

Evaluation of A Morning Dosing Of A New Medicine And Its Effects On Sleep At Bedtime In Subjects With Primary Insomnia

Completed
NCT00104403Phase 2

Study Of Prevention of Chemo-Induced Nausea and Vomiting Caused By Moderately Emetogenic Chemotherapy

Completed
NCT00280423Phase 2

Effects Of GW679769 On Sleep Onset And Maintenance And Next Day Functioning In Subjects With Primary Insomnia

Completed
NCT00169572Phase 2

Study for The Prevention Of Nausea in Cancer Patients Receiving Highly Emetogenic Cisplatin Based Chemotherapy

Completed
NCT00332046Phase 1

fMRI Study Comparing BOLD Activation Patterns Using GW679769 In Subjects With Social Anxiety Disorder

Completed

All 13 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
13